How should atropine be used and dosed for managing drooling in children/adolescents with neurologic drooling and in adults?

Atropine for Drooling: Clinical Use and Dosing

Sublingual atropine eye drops (1% solution, 1 drop three times daily) are effective and safe for managing chronic drooling in children and adults with neurologic conditions, representing the best-studied off-label approach with superior efficacy compared to other routes of administration. 1, 2, 3

Route of Administration and Formulation

Sublingual administration is superior to oral and subcutaneous routes for managing sialorrhea, based on meta-analysis of multiple administration methods 2. The most commonly studied approach uses:

• Atropine 1% ophthalmic solution (eye drops) administered sublingually 1, 4, 3
• This represents off-label use of an FDA-approved ophthalmic formulation 5

Key Advantage of Sublingual Route

• Direct absorption through oral mucosa minimizes systemic exposure 6
• Lower frequency of systemic anticholinergic side effects compared to oral anticholinergics 1, 4
• Pharmacokinetic studies show maximum plasma concentration of only 0.14 ng/mL with satisfactory safety profile 5

Dosing Regimens

Children and Adolescents with Neurologic Drooling

Start with conservative dosing and titrate based on response:

• Initial dose: 1 drop of atropine 10 mg/mL (1%) solution sublingually once daily 1
• Titration: After 4 weeks, increase to 1 drop twice daily if needed 1
• Alternative studied regimen: 1 drop three times daily has shown significant efficacy 4, 3

Clinical evidence shows:

• Once-daily dosing reduced drooling severity from median VAS score of 74 to 48 (p=0.05) 1
• Twice-daily dosing further reduced scores to 32 (p=0.004) 1
• Unstimulated salivary secretion rates decreased significantly (p=0.032) 1
• Drooling Impact Scale scores showed statistically significant improvement in cerebral palsy patients 4

Adults with Neurologic Drooling

Use the same sublingual approach as pediatric patients:

• Standard dose: 1 drop of 1% atropine solution sublingually three times daily 3
• In stroke patients, this regimen reduced mean sialorrhea scores from 5.12 to 3.94 (p<0.01) compared to rehabilitation alone 3

Special Population: Clozapine-Induced Hypersalivation

For acute nocturnal hypersalivation:

• Single dose: 600 μg (approximately 1 drop of 1% solution) sublingual atropine at bedtime 7
• This reduced saliva secretion by 57% compared to placebo (p=0.02) 7
• Patients reported subjectively drier pillows and improved sleep 7

Important Clinical Considerations

Administration Technique

• Place drop(s) under the tongue, not on top 1, 6
• Some parents report difficulty with administration in young children 1
• A mucoadhesive gel formulation is under development to address administration challenges 5

Safety Profile

• No irreversible side effects reported in pediatric studies 1, 4
• Significantly fewer systemic side effects compared to oral anticholinergics like glycopyrrolate 1, 4
• No significant changes in heart rate, blood pressure, or oxygen saturation at studied doses 5
• One study noted decreased standing pulse rate (-5.8 bpm, p=0.002) with 600 μg dose 7

Common Pitfalls to Avoid

• Do not use atropine formulations intended for cardiac emergencies (0.4 mg/mL concentration) for chronic drooling—these are for IV/IM use in bradycardia 8
• The ophthalmic 1% (10 mg/mL) formulation is specifically used for sublingual drooling management 1, 2
• Avoid confusing chronic drooling management with acute anticholinesterase poisoning, which requires much higher IV doses (0.05-0.1 mg/kg) 9

Monitoring

• Assess drooling severity using validated scales (Visual Analog Scale or Drooling Impact Scale) 1, 4
• Monitor for anticholinergic side effects: dry mouth, blurred vision, urinary retention, constipation 10
• Consider dose-dependent relationship with adverse events—start low and titrate slowly 10

Alternative Considerations

While glycopyrrolate remains the most studied oral anticholinergic for sialorrhea (52% of patients in systematic reviews), it has higher systemic side effect burden 10. Sublingual atropine offers a practical alternative when:

• Oral medications cause intolerable systemic effects 1, 4
• Targeted local effect is preferred over systemic anticholinergic therapy 6
• Patient or family prefers non-invasive approach over botulinum toxin injections 2